Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

In Vitro Selection of Cell-Internalizing DNA Aptamers in a Model System of Inflammatory Kidney Disease.

Ranches G, Lukasser M, Schramek H, Ploner A, Stasyk T, Mayer G, Mayer G, Hüttenhofer A.

Mol Ther Nucleic Acids. 2017 Sep 15;8:198-210. doi: 10.1016/j.omtn.2017.06.018. Epub 2017 Jun 27.

2.

Synergistic induction of CCL2/MCP-1 expression driven by oncostatin M and IL-1β in human proximal tubular cells depends on STAT3 and p65 NFκB/RelA.

Sarközi R, Corazza U, Osterkamp JP, Pirklbauer M, Mayer G, Schramek H.

Physiol Rep. 2015 Feb 22;3(2). pii: e12298. doi: 10.14814/phy2.12298. Print 2015 Feb 1.

3.

Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling.

Kern G, Mair SM, Noppert SJ, Jennings P, Schramek H, Rudnicki M, Mueller GA, Mayer G, Koppelstaetter C.

PLoS One. 2014 May 9;9(5):e96377. doi: 10.1371/journal.pone.0096377. eCollection 2014.

4.

Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells.

Sarközi R, Flucher K, Haller VM, Pirklbauer M, Mayer G, Schramek H.

Biochem Biophys Res Commun. 2012 Aug 10;424(4):801-6. doi: 10.1016/j.bbrc.2012.07.042. Epub 2012 Jul 16.

PMID:
22814105
5.

Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression.

Sarközi R, Hauser C, Noppert SJ, Kronbichler A, Pirklbauer M, Haller VM, Grillari J, Grillari-Voglauer R, Mayer G, Schramek H.

Am J Physiol Renal Physiol. 2011 Nov;301(5):F1014-25. doi: 10.1152/ajprenal.00123.2011. Epub 2011 Aug 3.

6.

Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells.

Schramek H, Sarközi R, Lauterberg C, Kronbichler A, Pirklbauer M, Albrecht R, Noppert SJ, Perco P, Rudnicki M, Strutz FM, Mayer G.

Lab Invest. 2009 Nov;89(11):1304-16. doi: 10.1038/labinvest.2009.96. Epub 2009 Sep 7.

7.

Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease.

Rudnicki M, Perco P, Enrich J, Eder S, Heininger D, Bernthaler A, Wiesinger M, Sarközi R, Noppert SJ, Schramek H, Mayer B, Oberbauer R, Mayer G.

Lab Invest. 2009 Mar;89(3):337-46. doi: 10.1038/labinvest.2008.158. Epub 2009 Jan 12.

8.

Bortezomib-induced survival signals and genes in human proximal tubular cells.

Sarközi R, Perco P, Hochegger K, Enrich J, Wiesinger M, Pirklbauer M, Eder S, Rudnicki M, Rosenkranz AR, Mayer B, Mayer G, Schramek H.

J Pharmacol Exp Ther. 2008 Dec;327(3):645-56. doi: 10.1124/jpet.108.142604. Epub 2008 Sep 5.

9.

Bone morphogenetic protein-4 strongly potentiates growth factor-induced proliferation of mammary epithelial cells.

Montesano R, Sarközi R, Schramek H.

Biochem Biophys Res Commun. 2008 Sep 12;374(1):164-8. doi: 10.1016/j.bbrc.2008.07.007. Epub 2008 Jul 14.

PMID:
18625198
10.

Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling.

Pollack V, Sarközi R, Banki Z, Feifel E, Wehn S, Gstraunthaler G, Stoiber H, Mayer G, Montesano R, Strutz F, Schramek H.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1714-26. Epub 2007 Sep 19.

11.

TGF-beta signaling and its effect on glutaminase expression in LLC-PK1-FBPase+ cells.

Andratsch M, Feifel E, Taylor L, O'Hayre M, Schramek H, Curthoys NP, Gstraunthaler G.

Am J Physiol Renal Physiol. 2007 Sep;293(3):F846-53. Epub 2007 Jun 27.

12.

ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.

Sarközi R, Miller B, Pollack V, Feifel E, Mayer G, Sorokin A, Schramek H.

J Cell Physiol. 2007 Apr;211(1):88-100.

PMID:
17131384
13.

HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways.

Wilflingseder D, Müllauer B, Schramek H, Banki Z, Pruenster M, Dierich MP, Stoiber H.

J Immunol. 2004 Dec 15;173(12):7497-505.

14.

Reduction of intracellular pH inhibits constitutive expression of cyclooxygenase-2 in human colon cancer cells.

Pirkebner D, Fuetsch M, Wittmann W, Weiss H, Haller T, Schramek H, Margreiter R, Amberger A.

J Cell Physiol. 2004 Feb;198(2):295-301.

PMID:
14603531
15.

Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.

Schramek H, Feifel E, Marschitz I, Golochtchapova N, Gstraunthaler G, Montesano R.

Am J Physiol Cell Physiol. 2003 Sep;285(3):C652-61. Erratum in: Am J Physiol Cell Physiol. 2003 Dec;285(6):C1561.

16.

Replicative senescence of human fibroblasts: the role of Ras-dependent signaling and oxidative stress.

Hütter E, Unterluggauer H, Uberall F, Schramek H, Jansen-Dürr P.

Exp Gerontol. 2002 Oct-Nov;37(10-11):1165-74.

PMID:
12470828
17.

p38 MAPK mediates acid-induced transcription of PEPCK in LLC-PK(1)-FBPase(+) cells.

Feifel E, Obexer P, Andratsch M, Euler S, Taylor L, Tang A, Wei Y, Schramek H, Curthoys NP, Gstraunthaler G.

Am J Physiol Renal Physiol. 2002 Oct;283(4):F678-88.

18.

MAP kinases: from intracellular signals to physiology and disease.

Schramek H.

News Physiol Sci. 2002 Apr;17:62-7. Review.

PMID:
11909994
19.

Rapid activation of Na+/H+-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2.

Gekle M, Freudinger R, Mildenberger S, Schenk K, Marschitz I, Schramek H.

Pflugers Arch. 2001 Mar;441(6):781-6.

PMID:
11316261
20.

Differential expression of cell-cell adhesion proteins and cyclin D in MEK1-transdifferentiated MDCK cells.

Marschitz I, Lechner J, Mosser I, Dander M, Montesano R, Schramek H.

Am J Physiol Cell Physiol. 2000 Nov;279(5):C1472-82.

Supplemental Content

Loading ...
Support Center